Robert Gray
Chief Executive Officer at NANOSTRING TECHNOLOGIES, INC.
Net worth: 39 300 $ as of 2024-03-30
Profile
Robert Bradley Gray is currently the President, Chief Executive Officer & Director at NanoString Technologies, Inc. He previously worked as the Vice President-Product & Business Development at Genzyme Genetics, Inc. from 2008 to 2010 and as the Director-Corporate Development at Genzyme Corp.
He has an undergraduate degree from the University of Oxford and another undergraduate degree from the Massachusetts Institute of Technology.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-03-04 | 491,247 ( 1.02% ) | 39 300 $ | 2024-03-30 |
Robert Gray active positions
| Companies | Position | Start |
|---|---|---|
| NANOSTRING TECHNOLOGIES, INC. | Chief Executive Officer | 2010-06-28 |
Former positions of Robert Gray
| Companies | Position | End |
|---|---|---|
Genzyme Genetics, Inc.
 Genzyme Genetics, Inc. Medical/Nursing ServicesHealth Services Genzyme Genetics, Inc. provides laboratory testing and diagnostic services specifically for reproductive and oncology tests. It provides tests for cystic fibrosis carriers and cancers. The company is headquartered in Westborough, MA. | Corporate Officer/Principal | 2010-04-30 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Training of Robert Gray
| University of Oxford | Undergraduate Degree |
| Massachusetts Institute of Technology | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| NANOSTRING TECHNOLOGIES, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Genzyme Genetics, Inc.
Genzyme Genetics, Inc. Medical/Nursing ServicesHealth Services Genzyme Genetics, Inc. provides laboratory testing and diagnostic services specifically for reproductive and oncology tests. It provides tests for cystic fibrosis carriers and cancers. The company is headquartered in Westborough, MA. | Health Services |
- Stock Market
- Insiders
- Robert Gray
